Regulus Therapeutics
RGLS
#8838
Rank
โ‚ฌ0.10 B
Marketcap
1,54ย โ‚ฌ
Share price
-6.39%
Change (1 day)
-33.90%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of December 2024 : โ‚ฌ76.78 Million

According to Regulus Therapeutics's latest financial reports the company's total assets are โ‚ฌ76.78 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ80.89 M190.82%
2023-12-31โ‚ฌ27.81 M-36.13%
2022-12-31โ‚ฌ43.55 M-27.95%
2021-12-31โ‚ฌ60.44 M97.71%
2020-12-31โ‚ฌ30.57 M-18.61%
2019-12-31โ‚ฌ37.56 M53.88%
2018-12-31โ‚ฌ24.41 M-62.36%
2017-12-31โ‚ฌ64.84 M-32.24%
2016-12-31โ‚ฌ95.69 M-25.83%
2015-12-31โ‚ฌ0.12 B-8.49%
2014-12-31โ‚ฌ0.14 B58.22%
2013-12-31โ‚ฌ89.11 M13.87%
2012-12-31โ‚ฌ78.25 M137.01%
2011-12-31โ‚ฌ33.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ68.06 B 88,543.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ126.05 B 164,060.56%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ25.58 B 33,220.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ94.90 B 123,484.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ3.86 B 4,936.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ92.71 M 20.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ84.47 B 109,904.63%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA